Key terms
About NEXI
NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NEXI news
Apr 05
4:24pm ET
NexImmune Announces Leadership Shift in Financial Management
Feb 06
5:07am ET
NexImmune Announces New Offerings in Recent Press Release
Feb 06
5:07am ET
NexImmune Delays Liquidation Vote for Financing Review
Feb 06
5:07am ET
NexImmune Equity Sales: Unregistered Securities and Private Placement
Feb 06
5:06am ET
NexImmune Secures Funding Through Equity and Warrant Sales
Feb 02
2:13pm ET
Neximmune announces $3.67M registered direct offering priced at-the-market
Feb 02
2:10pm ET
Neximmune terminates equity sales agreement and ATM program
Feb 02
2:10pm ET
Neximmune Inc trading resumes
Feb 02
2:00pm ET
Neximmune Inc trading halted, volatility trading pause
Jan 31
9:41am ET
Neximmune Inc trading resumes
Jan 31
9:36am ET
Neximmune Inc trading halted, volatility trading pause
Jan 30
9:57am ET
Neximmune Inc trading resumes
Jan 30
9:57am ET
Neximmune Inc trading resumes
Jan 30
9:52am ET
Neximmune Inc trading halted, volatility trading pause
Jan 29
12:09pm ET
Neximmune Inc trading resumes
Jan 29
12:04pm ET
Neximmune Inc trading halted, volatility trading pause
Jan 10
9:42am ET
Neximmune Inc trading resumes
Jan 10
9:37am ET
Neximmune Inc trading halted, volatility trading pause
Jan 09
9:44am ET
Neximmune Inc trading resumes
Jan 09
9:34am ET
Neximmune Inc trading halted, volatility trading pause
No recent press releases are available for NEXI
NEXI Financials
Key terms
Ad Feedback
NEXI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NEXI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range